Search

Issue
Title
Authors
Vol 86, No 9 (2014)
Pulmonary hypertension in Russia: The first results of the national register
Chazova I.E., Arkhipova O.A., Valieva Z.S., Nakonechnikov S.N., Martyniuk T.V.
Vol 84, No 4 (2012)
CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
Avdeev S.N.
Vol 87, No 5 (2015)
Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases
Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Novikova D.S., Markelova E.I., Volkov A.V.
Vol 84, No 3 (2012)
SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS
Neklyudova G.V., Avdeev S.N., Tsareva N.A., Chernyaev A.L., Samsonova M.V., Naumenko Z.K., Mikhale L.M.
Vol 82, No 4 (2010)
Tissue myocardial Doppler echocardiographic evaluation of right heart function and the level natriuretic peptides in patients with pulmonary hypertension of various etiologies
Andreeva Y.A., Saidova M.A., Martynyuk T.V., Masenko V.P., Chazova I.E., Andreeva Y.A., Saidova M.A., Martynyuk T.V., Masenko V.P., Chazova I.E.
Vol 78, No 3 (2003)
Role of some neurohumoral factors in the development of pulmonary hypertension in patients with interstitial Jung diseases
Arkhipova D.V., Kornev B.M., Popova E.N., Kogan E.A., Osipenko V.I., Privalova E.V., Kobylensky A.G., Mescheryakova S.A., Efremov E.E.
Vol 87, No 4 (2015)
HIV/AIDS masks in a therapist’s practice
Roshchina A.A., Ponomareva E.Y., Rebrov A.P.
Vol 88, No 9 (2016)
Role of vascular remodeling markers in the development of osteoporosis in idiopathic pulmonary arterial hypertension
Nevzorova V.A., Kochetkova E.A., Ugay L.G., Maistrovskaya Y.V., Khludeeva E.A.
PDF
(Rus)
Vol 87, No 1 (2015)
Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis
Volkov A.V., Kurmukov I.A., Iudkina N.N., Glukhova S.I., Nikolaeva E.V.
Vol 79, No 12 (2004)
Vasoregulating activity of the endothelium and pulmonary hypertension
Karoli N.A., Rebrov A.P.
Vol 89, No 3 (2017)
Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension
Moisseeva O.M., Rudakova A.V.
PDF
(Rus)
Vol 79, No 8 (2004)
Vasaprostan treatment of fibrosing alveolitis in patients withpulmonary hypertension
Popova E.N., Bolevich S.В., Litvitsky P.E., Arkhipova D.V., Osipenko V.I., Kogan E.A., Kornev В.М., Mukhin N.A.
Vol 88, No 7 (2016)
The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension
Avdeev S.N.
PDF
(Rus)
Vol 86, No 9 (2014)
Clinical guidelines for the diagnosis and treatment of pulmonary hypertension
Chazova I.E., Avdeev S.N., Tsareva N.A., Volkov A.V., Martyniuk T.V., Nakonechnikov S.N.
Vol 84, No 9 (2012)
Pulmonary hypertension in rheumatic heart disease: current approaches to diagnosis and therapy
Shostak N.A., Klimenko A.A., Novikov I.V., Demidova N.A., Aksenova A.V.
Vol 79, No 6 (2004)
Blockers of angiotensin receptors: a novel approach to treatment of secondary pulmonary hypertension
Butorov I.V., Verbitsky О.N., Butorov S.I.
Vol 88, No 6 (2016)
Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease
Rudenko T.E., Vasilyeva M.P., Solomakhina N.I., Kutyrina I.M.
PDF
(Rus)
Vol 86, No 3 (2014)
Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension
Avdeev S.N.
Vol 84, No 9 (2012)
Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension
Martyniuk T.V., Arkhipova O.A., Kobal' E.A., Danilov N.M., Chazova I.E.
Vol 79, No 3 (2004)
Prostaglandin E1. Mechanisms of action and clinical potentialities
Alferov A.V., Aizenberg L.V.
Vol 89, No 12 (2017)
Diagnosis and treatment of pulmonary hypertension: from the point of view of 2017
Sarybaev A.S., Sydykov A.S., Sartmyrzaeva M.A., Mamazhakypov A.T., Maripov A.M., Dzhumagulova A.S.
Vol 87, No 11 (2015)
Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study
Volkov A.V., Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Nasonov E.L.
Vol 86, No 5 (2014)
Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases
Volkov A.V., Iudkina N.N., Nikolaeva E.V., Kurmukov I.A., Glukhova S.I., Nasonov E.L.
Vol 84, No 5 (2012)
SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION, ASSOCIATED WITH SYSTEMIC SCLEROSIS
Volkov A.V., Martynyuk T.V., Yudkina N.N., Danilov N.M., Glukhova S.I., Guseva N.G., Chazova I.E., Nasonova V.A.
Vol 79, No 3 (2004)
Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension
Arkhipova D.V., Privalova E.V., Kozlovskaya L.V., Kornev B.M., Popova E.N., Kraeva V.V., Osipenko V.I., Bitsadze V.O.
1 - 25 of 25 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies